Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TANZANITE: Safety and Efficacy of Suprachoroidal CLS-TA in Combination With Intravitreal Aflibercept in Subjects With Macular Edema Following Retinal Vein Occlusion

NCT02303184 is registered in ClinicalTrials.gov with Clearside Biomedical, Inc. as lead sponsor.

NCT NCT02303184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02303184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TANZANITE: Safety and Efficacy of Suprachoroidal CLS-TA in Combination With Intravitreal Aflibercept in Subjects With Macular Edema Following Retinal Vein Occlusion
Lead sponsor
Clearside Biomedical, Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2015
Completion date
March 31, 2016
Enrollment
46 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

macular edema, retinal vein occlusion